Vigilare Wealth Management - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vigilare Wealth Management ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$226,000
-34.3%
6,996
-40.7%
0.19%
-8.4%
Q4 2021$344,000
-2.5%
11,796
-10.8%
0.20%
-6.9%
Q3 2021$353,000
+26.5%
13,221
+45.8%
0.22%
+29.0%
Q2 2021$279,000
+35.4%
9,071
+15.2%
0.17%
+15.8%
Q1 2021$206,0007,8710.15%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders